Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human Taste receptor type 1 member 3 (TAS1R3), partial CSB-YP752534HU
CSB-BP752534HU
CSB-MP752534HU
CSB-EP752534HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Ovochymase-2 (OVCH2) CSB-YP752535HU
CSB-EP752535HU
CSB-BP752535HU
CSB-MP752535HU
CSB-EP752535HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa ATP-dependent RNA helicase eIF4A (tif-1) CSB-YP752536NHA
CSB-EP752536NHA
CSB-BP752536NHA
CSB-MP752536NHA
CSB-EP752536NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Mannose-1-phosphate guanyltransferase (mpg-1) CSB-YP752537NHA
CSB-EP752537NHA
CSB-BP752537NHA
CSB-MP752537NHA
CSB-EP752537NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Eukaryotic translation initiation factor 3 subunit A (tif-32), partial CSB-YP752538NHA
CSB-EP752538NHA
CSB-BP752538NHA
CSB-MP752538NHA
CSB-EP752538NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Serine/threonine-protein kinase atg-1 (atg-1), partial CSB-YP752539NHA
CSB-EP752539NHA
CSB-BP752539NHA
CSB-MP752539NHA
CSB-EP752539NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (adi1) CSB-YP752540NHA
CSB-EP752540NHA
CSB-BP752540NHA
CSB-MP752540NHA
CSB-EP752540NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Signal peptidase complex catalytic subunit sec11 (sec11), partial CSB-YP752541NHA1
CSB-EP752541NHA1
CSB-BP752541NHA1
CSB-MP752541NHA1
CSB-EP752541NHA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Pre-mRNA-splicing factor rse-1 (rse-1), partial CSB-YP752542NHA
CSB-EP752542NHA
CSB-BP752542NHA
CSB-MP752542NHA
CSB-EP752542NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa tRNA (guanine-N (7)-)-methyltransferase (trm-8) CSB-YP752543NHA
CSB-EP752543NHA
CSB-BP752543NHA
CSB-MP752543NHA
CSB-EP752543NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Mitochondrial distribution and morphology protein 34 (mdm34), partial CSB-YP752544NHA
CSB-EP752544NHA
CSB-BP752544NHA
CSB-MP752544NHA
CSB-EP752544NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Serine/threonine-protein kinase tel-1 (tel-1), partial CSB-YP752545NHA
CSB-EP752545NHA
CSB-BP752545NHA
CSB-MP752545NHA
CSB-EP752545NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Nucleolar protein 16 (nop-16) CSB-YP752546NHA
CSB-EP752546NHA
CSB-BP752546NHA
CSB-MP752546NHA
CSB-EP752546NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa WD repeat-containing protein NCU09302/NCU11420 (NCU09302, NCU11420), partial CSB-YP752547NHA
CSB-EP752547NHA
CSB-BP752547NHA
CSB-MP752547NHA
CSB-EP752547NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa mRNA turnover protein 4 homolog (NCU07547) CSB-YP752548NHA
CSB-EP752548NHA
CSB-BP752548NHA
CSB-MP752548NHA
CSB-EP752548NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Kynurenine 3-monooxygenase (bna-4), partial CSB-YP752549NHA
CSB-EP752549NHA
CSB-BP752549NHA
CSB-MP752549NHA
CSB-EP752549NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Eukaryotic translation initiation factor 3 subunit B (prt-1), partial CSB-YP752550NHA
CSB-EP752550NHA
CSB-BP752550NHA
CSB-MP752550NHA
CSB-EP752550NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Metacaspase-1B (mca-2), partial CSB-YP752551NHA
CSB-EP752551NHA
CSB-BP752551NHA
CSB-MP752551NHA
CSB-EP752551NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Probable hexaprenyl pyrophosphate synthase, mitochondrial (NCU02305), partial CSB-YP752552NHA
CSB-EP752552NHA
CSB-BP752552NHA
CSB-MP752552NHA
CSB-EP752552NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Class E vacuolar protein-sorting machinery protein hse-1 (hse-1), partial CSB-YP752553NHA
CSB-EP752553NHA
CSB-BP752553NHA
CSB-MP752553NHA
CSB-EP752553NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>